CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionPrice-to-book is 0.3×, lower than 95% of its Medical Devices peers (median 2.69×)
- FinancialsAltman Z-Score 0.76: distress zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.35%
Annual Rate
KRW 200.00Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
29.6 yr
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
714.13BKRW505.63M · vs all stocks (USD)
Revenue (TTM)
718.78BKRW508.93M · vs all stocks (USD)
Profit Margin
-65.49%vs Medical Devices peers
Beta
0.6980xvs all stocks
52-Week Change
-41.76%vs all stocks
Market Capitalization
714.13BKRW505.63M · vs all stocks (USD)
Enterprise Value
601.02BKRW425.54M · vs all stocks (USD)
Forward P/E
-22.61xvs Medical Devices peers
Price to Sales (TTM)
1.02xvs Medical Devices peers
Price to Book (MRQ)
0.3008xvs Medical Devices peers
Enterprise to Revenue
0.8360xvs Medical Devices peers
Enterprise to EBITDA
12.35xvs Medical Devices peers
Gross Margin
52.04%vs Medical Devices peers
Profit Margin
-65.49%vs Medical Devices peers
Operating Margin
-6.98%vs Medical Devices peers
Return on Assets (TTM)
-1.51%vs Medical Devices peers
Return on Equity (TTM)
-17.98%vs Medical Devices peers
Revenue (TTM)
718.78BKRW508.93M · vs all stocks (USD)
Revenue per Share (TTM)
6.01KKRWUpdated Aug 19, 2026Quarterly Revenue Growth
4.40%vs Medical Devices peers
Gross Profit (TTM)
328.28BKRW232.44M · vs all stocks (USD)
EBITDA (TTM)
87.47BKRW61.93M · vs all stocks (USD)
Net Income (TTM)
-470.73BKRW-333.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.43%vs Medical Devices peers
Operating Cash Flow (TTM)
370.08BKRW262.03M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-27.45BKRW-19.44M · vs all stocks (USD)
Trailing Annual Dividend Rate
200.00KRWUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.35%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
7.18BKRWFY2025 · Dec 31, 2025Revenue
710.58BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
385.05BKRWFY2025 · Dec 31, 2025Gross Profit
325.53BKRWFY2025 · Dec 31, 2025Operating Income
-80.95BKRW-57.31M · vs all stocks (USD)
Pre-tax Income
-918.14BKRWFY2025 · Dec 31, 2025Income Tax Expense
-404.75BKRWFY2025 · Dec 31, 2025Net Income
-513.39BKRWFY2025 · Dec 31, 2025EBIT
-809.91BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
87.47BKRWFY2025 · Dec 31, 2025Research & Development
78.05BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
105.73BKRWFY2025 · Dec 31, 2025Other Operating Expenses
10.09BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
24.22BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
108.23BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-513.39BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
1.28BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-449.16BKRWFY2025 · Dec 31, 2025Free Cash Flow
-504.07BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
366.78BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-513.39BKRWFY2025 · Dec 31, 2025Stock-based Compensation
803.15MKRWFY2025 · Dec 31, 2025Other Non-cash Items
86.47BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-17.02BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.03BKRWFY2025 · Dec 31, 2025Capital Expenditures
-54.91BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-403.73MKRWFY2025 · Dec 31, 2025Net Acquisitions
-8.96BKRWFY2025 · Dec 31, 2025Purchase of Investments
-724.03BKRWFY2025 · Dec 31, 2025Sale of Investments
569.66BKRWFY2025 · Dec 31, 2025Other Investing Activity
1.04BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-217.21BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
14.93BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-2.03BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.12BKRWFY2025 · Dec 31, 2025Common Stock Repurchase
-11.57BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-24.18BKRWFY2025 · Dec 31, 2025Other Financing Charges
10.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-21.57BKRWFY2025 · Dec 31, 2025Shares Outstanding
119.62MSharesUpdated Aug 19, 2026Float Shares
32.04MSharesUpdated Aug 19, 2026% Held by Insiders
72.59%vs all stocks
% Held by Institutions
3.03%vs all stocks
Total Cash (MRQ)
497.60BKRW352.32M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.16KKRWUpdated Aug 19, 2026Total Debt (MRQ)
313.63BKRW222.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1321xvs Medical Devices peers
Current Ratio (MRQ)
5.07xvs Medical Devices peers
Book Value per Share (MRQ)
19.85KKRWUpdated Aug 19, 2026Total Assets
3.24TKRW2.30B · vs all stocks (USD)
Total Current Assets
1.23TKRWFY2025 · Dec 31, 2025Total Liabilities
905.85BKRWFY2025 · Dec 31, 2025Total Non-current Assets
2.01TKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
439.60BKRWFY2025 · Dec 31, 2025Total Current Liabilities
466.25BKRWFY2025 · Dec 31, 2025Cash Equivalents
366.78BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
366.78BKRWFY2025 · Dec 31, 2025Other Short-term Investments
407.39BKRWFY2025 · Dec 31, 2025Accounts Receivable
138.07BKRWFY2025 · Dec 31, 2025Inventory
222.11BKRWFY2025 · Dec 31, 2025Accounts Payable
51.75BKRWFY2025 · Dec 31, 2025Short-term Debt
311.66BKRWFY2025 · Dec 31, 2025Other Current Liabilities
870.00KRWFY2025 · Dec 31, 2025Long-term Debt
357.37BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-270.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
62.24BKRWFY2025 · Dec 31, 2025Retained Earnings
1.42TKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
2.34TKRW1.65B · vs all stocks (USD)
Treasury Stock
99.64BKRWFY2025 · Dec 31, 202552-Week Low
5.80KKRWUpdated Aug 19, 202652-Week High
10.93KKRWUpdated Aug 19, 202652-Week Change
-41.76%vs all stocks
Beta
0.6980xvs all stocks
50-Day MA
6.49KKRWUpdated Aug 19, 2026200-Day MA
8.08KKRWUpdated Aug 19, 2026Avg 10-Day Volume
141.20KSharesUpdated Aug 19, 2026Avg 30-Day Volume
121.72KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-4.28KKRWUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.3×, lower than 95% of its Medical Devices peers (median 2.69×)Notable
Price-to-book: 0.30Industry median: 2.69Industry P5: 0.66Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.52Profit Margin: -0.65
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 5.07Altman Z-Score: 0.76
Financial Health
Altman Z-Score 0.76: distress zoneCritical
Altman Z-Score: 0.76
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Daewoong Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Shen Lian Bio-Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Pku Healthcare Corporation Limited
Tier 1ProductionApproval-Gated PipelineRule
Valneva SE
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Aim Pharm Inc.
Tier 1ProductionApproval-Gated PipelineRule
Regenxbio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai ZJ Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hyundai Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pharmicell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk